126 related articles for article (PubMed ID: 1723537)
21. Effect of protein kinase inhibitors on the proliferation of leukemic cells stimulated by granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor or interleukin-3.
Tohda S; Nara N; Imai Y; Aoki N
Leukemia; 1991 Sep; 5(9):813-4. PubMed ID: 1719309
[TBL] [Abstract][Full Text] [Related]
22. Clinical use of hematopoietic growth factors in the myelodysplastic syndromes.
Ganser A; Hoelzer D
Semin Hematol; 1996 Jul; 33(3):186-95. PubMed ID: 8819229
[No Abstract] [Full Text] [Related]
23. Clinical trials of myeloid growth factors.
Glaspy JA; Golde DW
Exp Hematol; 1990 Nov; 18(10):1137-41. PubMed ID: 1698650
[No Abstract] [Full Text] [Related]
24. [Acute myeloid leukemias: role of growth factors to improve the efficacy of chemotherapy].
Viallard JF; David S; Grosset C; Puntous M; Lacombe F; Reiffers J
Presse Med; 1995 May 6-13; 24(17):822-6. PubMed ID: 7543203
[TBL] [Abstract][Full Text] [Related]
25. Effect of recombinant human stem cell factor on mafosfamide-treated bone marrow clonogenic cells.
Carlo-Stella C; Mangoni L; Almici C; Caramatti C; Rizzoli V
Stem Cells; 1993 Jul; 11 Suppl 2():170-4. PubMed ID: 7691323
[TBL] [Abstract][Full Text] [Related]
26. The in vitro effects of granulocyte and granulocyte-macrophage colony-stimulating factor on interleukin-3-dependent proliferation of human neonatal circulating progenitor cells.
Bedford Russell AR; Davies EG; Gibson FM; Gordon-Smith EC
Pediatr Res; 1995 May; 37(5):630-3. PubMed ID: 7541523
[TBL] [Abstract][Full Text] [Related]
27. Advances in the clinical use of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor to intensify cancer chemotherapy.
Fisher DC; Peters WP
Curr Opin Hematol; 1994 May; 1(3):221-7. PubMed ID: 9371286
[TBL] [Abstract][Full Text] [Related]
28. Interactions among colony-stimulating factors, IL-1 beta, IL-6, and kit-ligand in the regulation of primitive murine hematopoietic cells.
Muench MO; Schneider JG; Moore MA
Exp Hematol; 1992 Mar; 20(3):339-49. PubMed ID: 1373685
[TBL] [Abstract][Full Text] [Related]
29. Hexadecylphosphocholine stimulates the colony-stimulating factor-dependent growth of hemopoietic progenitor cells.
Vehmeyer K; Eibl H; Unger C
Exp Hematol; 1992 Jan; 20(1):1-5. PubMed ID: 1374341
[TBL] [Abstract][Full Text] [Related]
30. Hematopoietic growth factor therapy of myelodysplastic syndromes.
Arcenas AG; Vadhan-Raj S
Leuk Lymphoma; 1993; 11 Suppl 2():65-9. PubMed ID: 7510197
[No Abstract] [Full Text] [Related]
31. Effect of in vivo treatment with rh GM-CSF on in vitro growth of haematopoietic progenitors in patients with myelodysplastic syndromes.
Visani G; Tosi P; Finelli C; Gamberi B; Zauli G; Cenacchi A; Fogli M; Colombini R; Tura S
Haematologica; 1992; 77(2):142-5. PubMed ID: 1383105
[TBL] [Abstract][Full Text] [Related]
32. Treatment of myelodysplastic syndromes with hematopoietic growth factors.
Ganser A; Hoelzer D
Hematol Oncol Clin North Am; 1992 Jun; 6(3):633-53. PubMed ID: 1377194
[TBL] [Abstract][Full Text] [Related]
33. The myeloid colony-stimulating factors: introduction and overview.
Peters WP
Semin Hematol; 1991 Apr; 28(2 Suppl 2):1-5. PubMed ID: 1712123
[No Abstract] [Full Text] [Related]
34. Effect of interleukin-3 on responsiveness to granulocyte-colony-stimulating factor in severe aplastic anemia.
Geissler K; Forstinger C; Kalhs P; Knöbl P; Kier P; Kyrle P; Lechner K
Ann Intern Med; 1992 Aug; 117(3):223-5. PubMed ID: 1377461
[No Abstract] [Full Text] [Related]
35. [Low-dose granulocyte colony-stimulating factor combined with granulocyte-macrophage colony-stimulating factor for mobilizing peripheral CD34+ hematopoietic progenitor cells].
Meng FY; Xu B; Sun J; Yang Y; Niu JN
Di Yi Jun Yi Da Xue Xue Bao; 2004 Sep; 24(9):1051-2. PubMed ID: 15447861
[TBL] [Abstract][Full Text] [Related]
36. The current status of myeloid growth factor therapy.
Galvani DW
J R Coll Physicians Lond; 1991 Jul; 25(3):213-7. PubMed ID: 1717684
[TBL] [Abstract][Full Text] [Related]
37. [Clinical application of hematopoietic growth factor (IL-3, G-CSF, GM-CSF, and EPO)].
Motoyoshi K
Nihon Rinsho; 1992 Aug; 50(8):1967-72. PubMed ID: 1279240
[TBL] [Abstract][Full Text] [Related]
38. Cytokines in tumor therapy (GM-CSF, G-CSF, and IL-3). Proceedings of the satellite symposium to the 15th UICC Congress. Hamburg, Federal Republic of Germany, August 18, 1990.
Am J Clin Oncol; 1991; 14 Suppl 1():S1-63. PubMed ID: 1710873
[No Abstract] [Full Text] [Related]
39. Recombinant interleukin 3 induces interleukin 2 receptor expression on early myeloid cells in normal human bone marrow.
Gazzola MV; Collins NH; Tafuri A; Keever CA
Exp Hematol; 1992 Feb; 20(2):201-8. PubMed ID: 1371965
[TBL] [Abstract][Full Text] [Related]
40. High-dose therapy and autografting with peripheral blood stem cells in malignant lymphoma: granulocyte-macrophage colony-stimulating factor for stem cell mobilization.
Haas R; Hohaus S; Goldschmidt H; Möhle R; Witt B; Wannenmacher M; Hunstein W
Semin Oncol; 1994 Dec; 21(6 Suppl 16):19-24. PubMed ID: 7801144
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
